MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX) ("MedX†or the "Company†) is a data-driven health analytics business underpinned by proprietary intellectual property and regulated medical technologies. MedX's platform generates and analyses high-fidelity skin health data using patented imaging, Teledermatology, and Photobiomodulation systems, creating a growing, defensible data asset and IP moat. MedX operates as an ISO 13485–certified medical device manufacturer and maintains complian ...

Nov 6, 2025 6:00 PM Eastern Standard Time MedX Announces Final Closing of Non-Brokered Private Placement Share MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. ("MedX†or the "Company†) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated October 6, 2025, announcing an Initial Closing, it has completed final Closings of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated July 25, 2025. The Final Closings comprised the is ...

Sep 25, 2025 9:16 PM Eastern Daylight Time MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development Share MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX), ("MedX†or the "Company†), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Symon D. Cotton, accomplished medical device innovator and co-developer of SIAscopy®, as Strategic Advisor to the Company. Dr. Cotton is an experienced author and leader in ...